Literature DB >> 15151966

Assessment of monitor conditions for the display of radiological diagnostic images and ambient lighting.

C Wade1, P C Brennan.   

Abstract

Diagnostic efficacy is related to viewing conditions. An increasing number of radiology departments are using workstations for reporting and it was the aim of this study to assess monitor performance and ambient lighting in areas allocated to soft-copy reporting and review. The study was performed in 4 Dublin hospitals and 20 monitors were examined. Using a Society of Motion Pictures and Television Engineers' (SMPTE) test pattern, maximum luminance, spatial uniformity of luminance, temporal luminance stability, brightness and contrast resolution (gamma), geometry and ambient lighting was assessed. The results demonstrated that although temporal luminance stability and spatial uniformity appeared to be at acceptable levels, maximum luminance and gamma value variations were noted, with maximum luminance and geometry values often not complying with published guidelines. Cleaning the monitor face had no impact. 90% of viewing areas had acceptable ambient lighting levels. The data presented demonstrate that monitors examined were not operating at optimal levels for all performance parameters and inclusion of regular assessments of monitors should be part of an imaging department's ongoing quality assurance programme.

Entities:  

Mesh:

Year:  2004        PMID: 15151966     DOI: 10.1259/bjr/18928981

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  2 in total

1.  Diagnostic Accuracy and Visual Search Efficiency: Single 8 MP vs. Dual 5 MP Displays.

Authors:  Elizabeth A Krupinski
Journal:  J Digit Imaging       Date:  2017-04       Impact factor: 4.056

2.  Comparison of the commercial color LCD and the medical monochrome LCD using randomized object test patterns.

Authors:  Jay Wu; Tung H Wu; Rou P Han; Shu J Chang; Cheng T Shih; Jing Y Sun; Shih M Hsu
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.